FDA.reportPublic FDA data

Humalog Mix 50/50 100 UNT/ML Injectable Suspension

RxCUI
731281
RxNorm name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Display name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Full name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
021018Humalog Mix 50/50insulin lispro protamine and insulin lispro351(a)Disc2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Humalog Mix50/50 KwikPenINSULIN LISPROEli Lilly and Companyb34cd3ff-d0af-4852-b4ef-2a8b4a93aeae2026-01-13Warnings, Adverse reactionsExact identifier
rxcui: 731281

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b34cd3ff-d0af-4852-b4ef-2a8b4a93aeaeHumaLOG Mix 50/50 Injectable Suspension [PSN] · insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension [Humalog Mix] [SBD] · Humalog Mix 50/50 100 UNT/ML Injectable Suspension [SY]354These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 199920260113